Article citationsMore>>

Landolfi, R., Marchioli, R., Kutti, J., Gisslinger, H., Tognoni, G., Patrono, C., et al. (2004) Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera. The New England Journal of Medicine, 350, 114-124. https://doi.org/10.1056/NEJMoa035572

has been cited by the following article:

• TITLE: Recurrent Ischemic Stroke Revealing Polycythemia Vera

  AUTHORS: Ndiaga Matar Gaye, Moussa Toudou-Daouda, Nicolas Chausson, Djibril Soumah, Nana Rahamatou Tassiou, Didier Smadja

  KEYWORDS: Ischemic Stroke, Acute Coronary Syndrome, Recurrence, Polycythemia Vera, Antiplatelet Therapy

  JOURNAL NAME: Neuroscience and Medicine, Vol.13 No.1, March 11, 2022

  ABSTRACT: Background: Polycythemia vera is a possible cause of recurrent ischemic stroke which can be prevented. Aim: Describe a junctional ischemic stroke without large arterial trunks stenosis associated with an acute coronary syndrome. Case Presentation: A 66-years-old man was admitted for abrupt recurrent right hemiparesis related to bilateral and junctional ischemic stroke lesions. He had a medical history of a vertebrobasilar ischemic stroke concurrent with an acute coronary syndrome with normal coronary arteries. Transthoracic echocardiogram showed small apical akinesia. Hemoglobin level was 18.9 g/dl with a hematocrit of 57.6%. The endogenous erythropoietin was 1.3 mIU/ml with JAK2 V617F mutation positivity (37%). After eight months of treatment (hydroxycarbamide + aspirin + allopurinol) hemoglobin was 12.5 g/dL. Conclusion: This case illustrates the most suggestive features of PV particularly the ischemic stroke junctional topography.